An Illinois woman developed breast cancer after 11 years of taking the hormone replacement drugs Premarin and Prempro, manufactured by Wyeth and its parent company, Pfizer. She underwent a mastectomy on one breast and a preventive mastectomy on the other. After a five-and-a-half-week trial in Philadelphia, the jury returned a verdict of $34.3 million in her favor.
This result was obtained by our sister firm, Finkelstein & Partners.